M&A

Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)

Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)

Shots: Intas has acquired Coherus’ Udenyca business (incl. prefilled syringe...

Siemens to Acquire Dotmatics for $5.1B, Strengthening its Position in Life Science Market

Siemens to Acquire Dotmatics for $5.1B, Strengthening its Position in Life Science Market

Shots: Siemens has entered into an agreement to acquire Dotmatics for $5.1B from I...

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Shots: Paratek has entered into a definitive merger agreement to acquire Optinose...

Taiho Pharmaceutical to Acquire Araris Biotech for ~$1.1B

Taiho Pharmaceutical to Acquire Araris Biotech for ~$1.1B

Shots: Taiho Pharmaceutical has entered into a definitive agreement to acquire Ara...

Endo & Mallinckrodt Pharmaceuticals to Form a Combine Entity with $6.7B Cash-and-Stock

Endo & Mallinckrodt Pharmaceuticals to Form a Combine Entity with $6.7B Cash-and-Stock

Shots: Mallinckrodt & Endo to combine their generic pharmaceuticals & Endo...

AstraZeneca to acquire EsoBiotec for ~$1B

AstraZeneca to acquire EsoBiotec for ~$1B

Shots: AstraZeneca to acquire EsoBiotec, which will operate as AstraZeneca’s...

Image